Randomized trial demonstrates reduced incidence of breast cancer-related lymphedema following intervention, implying potential for better patient outcomes.
Preliminary results of our RCT show that ILR after ALND decreases BCRL incidence. Our goal is to finish the accrual of 174 patients with 24-month follow-up.
No takes yet. Share an insight, caveat, or question.
Coriddi et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: